These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35025800)

  • 1. 177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
    Kaghazchi F; Aghdam RA; Haghighi S; Vali R; Adinehpour Z
    Clin Nucl Med; 2022 Mar; 47(3):e243-e245. PubMed ID: 35025800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
    Cheng Z; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68 Ga-FAPI-46 and 18 F-FDG in Advanced Metastatic Pancreatic Cancer.
    Kaghazchi F; Divband G; Amini H; Adinehpour Z; Akbarian Aghdam R
    Clin Nucl Med; 2022 Oct; 47(10):e666-e669. PubMed ID: 35714370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
    Chen H; Pang Y; Meng T; Yu X; Sun L
    Clin Nucl Med; 2021 May; 46(5):424-426. PubMed ID: 33782300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
    Xie F; Fu L; Zhou W
    Clin Nucl Med; 2022 Dec; 47(12):e758-e759. PubMed ID: 36342807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
    Tatar G; Beyhan E; Erol Fenercioğlu Ö; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Sep; 47(9):e596-e599. PubMed ID: 35930714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the diagnostic efficacy of
    Zhang Z; Jia G; Pan G; Cao K; Yang Q; Meng H; Yang J; Zhang L; Wang T; Cheng C; Zuo C
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2877-2888. PubMed ID: 35243518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Fu H; Fu J; Huang J; Pang Y; Chen H
    Clin Nucl Med; 2021 Nov; 46(11):940-942. PubMed ID: 34034326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer.
    Gong W; Yang X; Wu J; Ou L; Zhang C
    Clin Nucl Med; 2022 Jan; 47(1):73-75. PubMed ID: 34874351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT in Patients With SAPHO Syndrome.
    Wang P; Li C; Hou G; Li Z; Jing H; Zhang W; Li F
    Clin Nucl Med; 2023 Sep; 48(9):781-784. PubMed ID: 37543757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.
    Kiran MY; Has Simsek D; Sanli Y; Kuyumcu S
    Clin Nucl Med; 2023 Feb; 48(2):e87-e88. PubMed ID: 36607380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
    Deng M; Chen Y; Cai L
    Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-FAPI PET imaging monitors response to combined TGF-βR inhibition and immunotherapy in metastatic colorectal cancer.
    Li K; Liu W; Yu H; Chen J; Tang W; Wang J; Qi M; Sun Y; Xu X; Zhang J; Li X; Guo W; Li X; Song S; Tang S
    J Clin Invest; 2024 Jan; 134(4):. PubMed ID: 38175716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.